| ID LINK | NAME | STRUCTURE CAS | CLOGP | CLOGS | MW | THERAPEUTIC AREA |
|---|---|---|---|---|---|---|
| FDBD00223 | Omeprazole |
 73590-58-6 |
3.162 | -5.867 | 345.416 | Omeprazole is indicated for the treatment of duodenal ulcers, benign gastric ulcers, gastroesophageal reflux disease (GERD), heartburn and other symptoms associated with GERD, erosive esophagitis, and long-term treatment of pathological hypersecretory conditions like Zollinger-Ellison syndrome, multiple endocrine adenomas, and systemic mastocytosis. |
| FDBD00224 | Pyrazinamide |
 98-96-4 |
0.078 | -0.743 | 123.113 | For the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents. |
| FDBD00225 | Metixene |
 4969-02-2 |
4.717 | -5.126 | 309.468 | Used for the symptomatic treatment of parkinsonism. |
| FDBD00226 | Cetirizine |
 83881-51-0 |
3.353 | -4.258 | 388.888 | For the relief of symptoms associated with seasonal allergic rhinitis, perennial allergic rhinitis and the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria. |
| FDBD00227 | Diltiazem |
 42399-41-7 |
2.826 | -4.442 | 414.518 | For the treatment of Hypertension. |
| FDBD00228 | Protriptyline |
 438-60-8 |
4.415 | -5.490 | 263.377 | For the treatment of depression. |
| FDBD00229 | Aminohippurate |
 61-78-9 |
-0.044 | -1.216 | 194.187 | Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism. |
| FDBD00230 | Alfuzosin |
 81403-80-7 |
1.459 | -4.411 | 389.449 | For the reduction of urinary obstruction and relief of associated manifestations (eg. sensation of incomplete bladder emptying or straining, urgency, interrupted or weak stream) in patients with symptomatic beningn prostatic hyperplasia. |
| FDBD00231 | Trimethadione |
 127-48-0 |
0.370 | -0.691 | 143.141 | Used in the control of absence (petit mal) seizures that are refractory to treatment with other medications. |
| FDBD00232 | Nitisinone |
 104206-65-7 |
2.853 | -3.974 | 329.228 | Used as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type 1. |
2911 ,
292
